Lipoprotein LAB (LLAB) is a research group dedicated to advance the field of pharmaceutics by exploring the underlying mechanisms that govern the behavior and functions of lipoproteins, their associated enzymes and receptors during the reverse cholesterol transport (RCT). By gaining a deeper understanding of mechanisms in RCT, we aim to develop novel pharmaceuticals for cardiovascular diseases and drug delivery purposes. In our research, we integrate molecular dynamics simulations with experimental techniques to reveal atomistic-scale insights into how lipoproteins and their associated proteins perform their biological functions.